Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) CEO Kim Rivers sold 380,000 shares of the stock in a transaction that occurred on Tuesday, June 23rd. The stock was sold at an average price of $8.47, for a total value of $3,218,600.00. Following the sale, the chief executive officer directly owned 2,313,724 shares of the company’s stock, valued at approximately $19,597,242.28. The trade was a 14.11% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trulieve Cannabis Stock Up 0.7%
Shares of TRLV opened at $8.56 on Friday. Trulieve Cannabis Corp. has a twelve month low of $3.50 and a twelve month high of $13.28.
Analyst Ratings Changes
A number of equities research analysts recently commented on TRLV shares. Weiss Ratings started coverage on shares of Trulieve Cannabis in a report on Tuesday, June 16th. They set a “sell (d-)” rating on the stock. Zacks Research upgraded Trulieve Cannabis to a “hold” rating in a report on Thursday, June 18th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce”.
Trulieve Cannabis Company Profile
Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.
Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.
Featured Articles
- Five stocks we like better than Trulieve Cannabis
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
